Similarly, the expression of HIGD1A in different cellular and animal models of mitochondrial disease was shown to attenuate their deleterious phenotypes by increasing CIV activity and ATP production while decreasing ROS levels [32]. The gene discussed is HIGD1A; the disease is inborn mitochondrial metabolism disorder.